State Street Corporation 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:02 am Sale |
2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
STATE STREET CORP STT |
2,427,284 1.440% |
-6,739,124 (-73.52%) |
Filing |
| 2023-02-03 3:52 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
STATE STREET CORP STT |
9,166,408 6.360% |
9,166,408 (New Position) |
Filing |